Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sensulin
company
About
Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $230K
- Industries
- Biotechnology,Diabetes,Health Care
- Founded date
- Aug 9, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sensulin, LLC is developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$230K
Sensulin has raised a total of
$230K
in funding over 2 rounds. Their latest funding was raised on
Dec 11, 2013 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 11, 2013 | Grant | $230K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Sensulin is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
